Market By Drug Type, Technology, Service, End-user, And Geography | Forecast 2019-2028
The drug discovery market in Latin America is estimated to grow at a CAGR of 5.88% for forecasting the years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in the
Latin America drug discovery market are:
• Mexico
• Brazil
• Rest of Latin America
countries
Both local as well as
international companies have been forming partnerships for activities like drug
discovery, product licensing, and co-marketing agreements. Further, there are
several policies in place for developing and maintaining a better marketing and
distribution infrastructure in Argentina. This is further encouraging local and
multinational players to enter into licensing and distribution agreements. In
addition, Argentina has a well-established regulatory system, which is one of
the key factors promoting the drug discovery market growth in the country.
Partnerships among leading
scientists based in Europe, North America, and Brazil have been providing
open-access research into drug discovery. This has propelled the growth of the
Brazilian drug discovery market. For instance, due to these partnerships,
significant grants have been allocated to fund Brazil’s first open-access
research facility into kinase types. However, the absence of proper policies to
secure doctors & masters in their home country, the poor stimulus to
science in general, erratic investments by government bodies, and relative
isolation from international practices are factors restraining the growth of
Brazil’s drug discovery market.
Founded in 1891, Merck &
Co Inc is a provider of healthcare solutions. It has its business operations in
four segments, such as pharmaceutical, animal health, healthcare services, and
alliances segments. The company offers preventive and therapeutic agents for
the treatment of cardiovascular diseases, type 2 diabetes, nasal allergy
symptoms, asthma, allergic rhinitis, HIV-1 infection, chronic hepatitis C virus
fungal infections, hypertension, intra-abdominal infections, arthritis,
osteoporosis, and inflammatory & fertility diseases. It also offers
cholesterol modifying medicines, antibacterial products, neuromuscular blocking
agents, and vaginal drug discovery products. It has a notable presence in Latin
America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA DRUG DISCOVERY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER'S
FIVE FORCES MODEL
2.2.1. THREATS
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. COVID-19
AND ITS IMPACT ON DRUG DISCOVERY MARKET
2.4. PESTLE
OUTLOOK
2.5. REGULATORY
FRAMEWORK
2.6. VALUE
CHAIN OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGED POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS
2.9.3. RISE
IN HEALTHCARE EXPENDITURE
2.9.4. SURGE
IN LIFESTYLE-ORIENTED DISEASES
2.10.
MARKET RESTRAINTS
2.10.1. DELAY IN PRODUCT LAUNCHES
2.10.2. RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS
2.11. MARKET OPPORTUNITIES
2.11.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES
IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES
2.11.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.12. MARKET CHALLENGES
2.12.1. POOR REIMBURSEMENTS POLICIES IN EMERGING
NATIONS
2.12.2. STRINGENT GOVERNMENT REGULATIONS
3. DRUG
DISCOVERY MARKET OUTLOOK - BY DRUG TYPE
3.1. SMALL
MOLECULE DRUG
3.2. BIOLOGIC
DRUG
4. DRUG
DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY
4.1. HIGH
THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS
AND PHARMACOGENETICS
4.5. COMBINATORIAL
CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER
TECHNOLOGIES
5. DRUG
DISCOVERY MARKET OUTLOOK - BY SERVICE
5.1. DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL
SERVICES
5.3. BIOLOGICAL
SERVICES
5.4. OTHER
PHARMACEUTICAL SERVICES
6. DRUG
DISCOVERY MARKET OUTLOOK - BY END-USER
6.1. RESEARCH
INSTITUTES
6.2. PHARMACEUTICAL
COMPANIES
6.3. CONTRACT
RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER
END-USERS
7. DRUG
DISCOVERY MARKET – LATIN AMERICA
7.1. COUNTRY
ANALYSIS
7.1.1. BRAZIL
7.1.2. MEXICO
7.1.3. REST
OF LATIN AMERICA
8. COMPANY
PROFILES
8.1. 3M
COMPANY
8.2. ABBOTT
LABORATORIES INC
8.3. AGILENT
TECHNOLOGIES INC
8.4. ANTARES
PHARMA INC
8.5. ASTRAZENECA
PLC
8.6. BAYER
AG
8.7. BECTON
DICKINSON & COMPANY (BD)
8.8. BOEHRINGER
INGELHEIM
8.9. ELI
LILY AND COMPANY
8.10. F HOFFMANN-LA ROCHE LTD
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO INC
8.14. NOVARTIS
8.15. PFIZER INC
8.16. SANOFI
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($
MILLION)
TABLE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028
($ MILLION)
TABLE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028
($ MILLION)
TABLE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($
MILLION)
TABLE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028
($ MILLION)
TABLE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY
COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 LATIN AMERICA DRUG DISCOVERY MARKET, BY
REGION, 2019-2028 ($ MILLION)
FIGURE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY
SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)
FIGURE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC
DRUG, 2019-2028 ($ MILLION)
FIGURE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY
HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)
FIGURE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY
BIOCHIPS, 2019-2028 ($ MILLION)
FIGURE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY
BIOINFORMATICS, 2019-2028 ($ MILLION)
FIGURE 7 LATIN AMERICA DRUG DISCOVERY MARKET, BY
PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)
FIGURE 8 LATIN AMERICA DRUG DISCOVERY MARKET, BY
COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)
FIGURE 9 LATIN AMERICA DRUG DISCOVERY MARKET, BY
NANOTECHNOLOGY, 2019-2028 ($ MILLION)
FIGURE 10 LATIN AMERICA DRUG DISCOVERY MARKET, BY
SPECTROSCOPY, 2019-2028 ($ MILLION)
FIGURE 11 LATIN AMERICA DRUG DISCOVERY MARKET, BY
METABOLOMICS, 2019-2028 ($ MILLION)
FIGURE 12 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER
TECHNOLOGIES, 2019-2028 ($ MILLION)
FIGURE 13 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)
FIGURE 14 LATIN AMERICA DRUG DISCOVERY MARKET, BY
CHEMICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 15 LATIN AMERICA DRUG DISCOVERY MARKET, BY
BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 16 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER
PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 17 LATIN AMERICA DRUG DISCOVERY MARKET, BY
RESEARCH INSTITUTES, 2019-2028 ($ MILLION)
FIGURE 18 LATIN AMERICA DRUG DISCOVERY MARKET, BY
PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)
FIGURE 19 LATIN AMERICA DRUG DISCOVERY MARKET, BY
CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)
FIGURE 20 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER
END-USERS, 2019-2028 ($ MILLION)
FIGURE 21 BRAZIL DRUG DISCOVERY MARKE 2019-2028 ($
MILLION)
FIGURE 22 MEXICO DRUG DISCOVERY MARKET 2019-2028 ($
MILLION)
FIGURE 23 REST OF LATIN AMERICA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)